<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: interferon alpha</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US</title>
   	 <description>Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007.  Treatment rates appear to be declining, in part because only half of the patients know they are infected.  If this disturbing trend continues, by 2030 less than 15% of liver-related deaths from HCV will be prevented by antiviral therapy.  This study, the first to analyze nationwide practice patterns for HCV treatment, is published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.</description>
     <link>http://www.physorg.com/news178264993.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 24 Nov 2009 06:50:01 EST</pubDate>
	 <guid isPermaLink="false">news178264993</guid>
</item>
<item>
     <title>Interferon alpha can delay full onset of type I diabetes</title>
   	 <description>A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.</description>
     <link>http://www.physorg.com/news165656173.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Jul 2009 09:10:01 EST</pubDate>
	 <guid isPermaLink="false">news165656173</guid>
</item>
<item>
     <title>Immunologists identify biochemical signals that help immune cells remember how to fight infection</title>
   	 <description>May 28, 2009 - Immunology researchers at UT Southwestern Medical Center have discovered how two biochemical signals play unique roles in promoting the development of a group of immune cells employed as tactical assassins.</description>
     <link>http://www.physorg.com/news162708029.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 May 2009 05:41:59 EST</pubDate>
	 <guid isPermaLink="false">news162708029</guid>
</item>
<item>
     <title>Interferon needed for cells to 'remember' how to defeat a virus</title>
   	 <description>Scientists at UT Southwestern Medical Center have determined that the immune-system protein interferon plays a key role in "teaching" the immune system how to fight off repeated infections of the same virus.</description>
     <link>http://www.physorg.com/news147506941.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 03 Dec 2008 06:09:01 EST</pubDate>
	 <guid isPermaLink="false">news147506941</guid>
</item>


</channel>
</rss>

